menu
    • menu

    Company profile for CoRegen

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    CoRegen is dedicated to advancing life-changing therapies with innovation and purpose. Our mission is to pioneer next-generation treatments that target a broad range of chronic illnesses, pushing the boundaries of modern medicine. Driven by cutting-edge biotechnology, rigorous research, and a deep commitment to patient care, we are reshaping the future of healthcare. CoRegen stands firmly on these core principles.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    CoRegenUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Houston, TX 77030
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.coregen.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Coregen Reveals SRC-3 Engineered Regulatory T Cells
    Coregen Reveals SRC-3 Engineered Regulatory T Cells

    17 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/17/3257094/0/en/CoRegen-Inc-Publishes-Promising-New-Data-Highlighting-SRC-3-Engineered-Regulatory-T-Cells-as-New-Immunotherapy-Platform.html

    GLOBENEWSWIRE
    17 Mar 2026
    Share Share
    CoRegen Appoints Sonja Nelson as CFO and Peter Gelinas as CTO
    CoRegen Appoints Sonja Nelson as CFO and Peter Gelinas as CTO

    10 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/10/3147709/0/en/CoRegen-Inc-Strengthens-Leadership-Team-with-the-Appointments-of-Sonja-Nelson-as-Chief-Financial-Officer-and-Peter-Gelinas-as-Chief-Technical-Officer.html

    GLOBENEWSWIRE
    10 Sep 2025
    Share Share
    CoRegen Hires Biotech Veteran Sonal as Chief Medical Officer
    CoRegen Hires Biotech Veteran Sonal as Chief Medical Officer

    31 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/31/3125077/0/en/CoRegen-Inc-Appoints-Biotech-Veteran-Sonal-Gupta-M-D-Ph-D-as-Chief-Medical-Officer.html

    GLOBENEWSWIRE
    31 Jul 2025
    Share Share
    CoRegen Closes More Than $93 Million Financing
    CoRegen Closes More Than $93 Million Financing

    09 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/09/3112516/0/en/CoRegen-Inc-Closes-More-Than-93-Million-Financing.html

    GLOBENEWSWIRE
    09 Jul 2025
    Share Share
    CoRegen Appoints Edward J. Benz, M.D., to its Board of Directors
    CoRegen Appoints Edward J. Benz, M.D., to its Board of Directors

    16 Nov 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/11/16/2782009/0/en/CoRegen-Appoints-Edward-J-Benz-M-D-to-its-Board-of-Directors.html

    GLOBENEWSWIRE
    16 Nov 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search